Wada, Takeshi http://orcid.org/0000-0001-5220-3342
Yamakawa, Kazuma
Kabata, Daijiro
Abe, Toshikazu
Fujishima, Seitaro
Kushimoto, Shigeki
Mayumi, Toshihiko
Ogura, Hiroshi
Saitoh, Daizoh
Shiraishi, Atsushi
Otomo, Yasuhiro
Gando, Satoshi
Sasaki, Junichi
Kotani, Joji
Takeyama, Naoshi
Tsuruta, Ryosuke
Takuma, Kiyotsugu
Yamashita, Norio
Shiraishi, Shin-ichiro
Ikeda, Hiroto
Shiino, Yasukazu
Tarui, Takehiko
Nakada, Takaaki
Hifumi, Toru
Okamoto, Kohji
Sakamoto, Yuichiro
Hagiwara, Akiyoshi
Masuno, Tomohiko
Ueyama, Masashi
Fujimi, Satoshi
Umemura, Yutaka
Mizobata, Yasumitsu
Yamada, Yasuo
Sugiyama, Satoru
Ishida, Hiroshi
Narimatsu, Eichi
Miyasho, Koji
Kanai, Toshio
Miyatake, Satoru
Iiduka, Ryouji
Imamura, Hiroshi
Mizushima, Yasuaki
Sato, Yoshitake
Nemoto, Manabu
Hanada, Hiroyuki
Shichinohe, Yasuo
Hirahara, Kenji
Kon, Akihide
Sugita, Manabu
Naoe, Yasutaka
Kirita, Manabu
Sadamitsu, Daikai
Yoshida, Masahiro
,
Funding for this research was provided by:
The Japanese Association for Acute Medicine (JAAM, 2014-01)
Article History
Received: 6 December 2022
Accepted: 23 February 2023
First Online: 5 March 2023
Declarations
:
: This study was approved by the JAAM and the Ethics Committee of all participating hospitals waiving written informed consent (JAAM, 2014-01, Hokkaido University Graduate School of Medicine, Head institute of the FORECAST group, 014-0307) since these were already previously obtained from each patient or their next of kin.
: Not applicable.
: None of the authors declare any conflicts of interests in connection with the submitted article. TW reported receiving research funding from Takeda Science Foundation and personal fees from Asahi Kasei Pharma America Inc. and Asahi Kasei Pharma Japan Inc. outside the submitted work. AS reported receiving personal fees from CSL Behring outside the submitted work. All other authors have no conflicts of interest to declare.